CD24 and colorectal carcinoma: Studies indicate that up-regulation of CD24 might be a feasible mechanism of resistance in colorectal cancer CRC, improving CRC cells' sensitivity to oxaliplatin (L-OHP)-induced cytotoxicity by GRP78 suppression, is closely correlated with down-regulation of CD24.